These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Control hematologic patterns in relation to the whole body dose following 131-I incorporation]. Simon A, Pfannenstiel P, Heimpel H, Hoffmann G. Strahlenschutz Forsch Prax; 1968 Mar; 8():209-16. PubMed ID: 5760480 [No Abstract] [Full Text] [Related]
3. [STUDY OF THE CHANGES IN THE BLOOD PICTURE AFTER THE THERAPEUTIC USE OF I-131 IN THYROTOXICOSIS]. PODOBOVA NEPELOVA L. Bratisl Lek Listy; 1963 Mar; 43():393-404. PubMed ID: 14058889 [No Abstract] [Full Text] [Related]
4. [ON HEMATOLOGIC INDICES IN HEALTHY YOUNG MALES]. MIKHAILOV A, KRYLOV AA, TOLSTOPIATOVA NS, DENISOVA LA, ANIKINA LV, KHRIPUNKOV DE, TITKOV SI. Voen Med Zh; 1964 Mar; 11():68-70. PubMed ID: 14278544 [No Abstract] [Full Text] [Related]
6. POLYCYTHEMIA VERA AND PREGNANCY: REPORT OF A CASE. RUCH WA, KLEIN RL. Obstet Gynecol; 1964 Jan; 23():107-11. PubMed ID: 14110040 [No Abstract] [Full Text] [Related]
7. The use of thyroid-stimulating hormone-Edecrine pretreatment in the radioiodide therapy of metastatic thyroid cancer. Clinical tolerance and changes in the radioiodine kinetics. Nĕmec J, Silink K, Neradilová M, Zamrazil V, Vána S, Cenková V. Neoplasma; 1972 Jan; 19(2):125-33. PubMed ID: 4112457 [No Abstract] [Full Text] [Related]
8. [Screening and rapid tests in hematology]. Schneider W. Internist (Berl); 1976 Sep; 17(9):425-9. PubMed ID: 786931 [No Abstract] [Full Text] [Related]
18. [Evaluation of the initial results obtained in the Program for Quality Control in Hematology. Organized by the Spanish Associations of Hematology and Hemotherapy, and Clinical Biopathology]. Aznar J, Teruel M, Bolufer P. Sangre (Barc); 1982 Mar; 27(5):973-81. PubMed ID: 7167852 [No Abstract] [Full Text] [Related]